The impact of the migraine treatment onabotulinumtoxinA on inflammatory and pain responses: Insights from an animal model

CONCLUSION: Our investigation highlights the role of BoNT/A in reducing baseline CGRP in the context of inflammation and its involvement in SNAP-25 cleavage. In contrast, BoNT/A did not appear to alter facial pain sensitivity induced by inflammation, suggesting that mechanisms other than baseline CGRP could be implicated in the elevated thresholds in the CFA model.PMID:38700141 | DOI:10.1111/head.14726
Source: Headache - Category: Neurology Authors: Source Type: research